Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xilio Therapeutics (XLO) Prepaid Assets (2024 - 2025)

Historic Prepaid Assets for Xilio Therapeutics (XLO) over the last 2 years, with Q3 2025 value amounting to $2.8 million.

  • Xilio Therapeutics' Prepaid Assets rose 3780.49% to $2.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.8 million, marking a year-over-year increase of 3780.49%. This contributed to the annual value of $4.9 million for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, Xilio Therapeutics' Prepaid Assets is $2.8 million, which was up 3780.49% from $2.2 million recorded in Q2 2025.
  • Xilio Therapeutics' 5-year Prepaid Assets high stood at $5.2 million for Q1 2024, and its period low was $2.0 million during Q3 2024.